Laviolette Paul A
- SEC CIK
- 0001191249
In the past year, 1 open-market purchase filing worth $295.4K and no sales.
Current role at each company
- PLSE Pulse Biosciences, Inc.Chief Executive Officeras of May 11, 2026
- EW Edwards Lifesciences CorpDirectoras of May 8, 2026
- MSON Misonix IncDirectoras of Dec 8, 2021
- ASXC Asensus Surgical, Inc.Directoras of Jul 2, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $295.4K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$295.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Laviolette Paul A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PLSE Pulse Biosciences, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 (view filing) | May 11 | Same day | Laviolette Paul AChief Executive Officer | PPurchase | +15.0K | $19.69 | +$295.4K | +1,773.0%15.8K after | Amended |